Double Bond Pharmaceutical at Life Science-day in Gothenburg 2016

| March 11, 2016

article image
Igor Lokot, CEO at Double Bond Pharmaceutical, holding a talk and answering questions about company's products and development at Life Science-day in Gothenburg…

Spotlight

Genetics Society of America

The mission of the Genetics Society of America (GSA) is to deepen our understanding of the living world by advancing the field of genetics. It does this by: Fostering an international community of geneticists by promoting interaction among geneticists (including microbial, plant, animal, human, and population and theoretical geneticists) while cultivating a community of thought leaders in the field. Ensuring genetics fulfills its potential for broad impact by facilitating the application of genetic tools and approaches in biological research.

OTHER ARTICLES

How Pharma Companies Can Scale Up Their Knowledge Discovery with Semantic Similarity Search

Article | March 6, 2020

Pharma has deep roots in human history with centuries of folk pharmaceutical knowledge offering a hit-and-miss range of natural remedies. But the industry as we know it today actually emerged in the second half of the 19th century when the world’s first factory for the sole production of medicines was found. By the late 19th and early 20th century, some chemical companies had already begun using research labs to explore the medical applications for their products. Fast forward to today and the pharmaceutical sector is a global trillion-dollar industry. However, to ensure the safety and efficacy of drugs, the process of drug discovery and development is under extensive scrutiny and control on both national and global levels.

Read More

How AI and Big Data Will Disrupt Pharma’s Regulatory Compliance Standards

Article | March 6, 2020

The industry as we know it is changing. Pharmaceutical and life sciences companies across the globe are experiencing more pressure than ever to keep up with increased regulatory standards while moving at a pace that requires them to innovate in order to remain competitive. With more real-time automation and the steady increase in AI and Big Data sweeping the landscape, what used to be a slow-to-change and risk-averse industry is now expected to see a significant shift towards newer technology that focus on heightened regulatory standards. Here’s how your company can get ahead of what industry experts are calling, Pharma

Read More

Five Ways to Manage Your Trial Effectively in a Fast-Changing Global Environment

Article | March 6, 2020

Over the past half-century, clinical trials have grown increasingly complex. A flood of new data from novel sources combined with more elaborate study designs and tougher regulatory standards have lengthened timelines and hiked costs, contributing to a steady decline of efficiency. It all adds up: Nearly half of all drug launches underperform revenue expectations. And if that isn’t enough, the outbreak of COVID-19 worldwide is having an effect on how life sciences companies operate their businesses, including how clinical trials are conducted. Most clinical trial research organizations have tried to adapt by tweaking a platform here, adding a new app there, but this has only yielded patchwork systems of sites, spreadsheets and dashboards that further burden the process.

Read More

Clinical Supply Availability & Speed to Study Start-Up

Article | March 6, 2020

If you’re part of a clinical study team racing a new product to commercialization, you likely live by these two simple rules: time is money, and the first one to market wins. But just because it’s simple doesn’t mean it’s easy. That ticking clock is background noise to the responsibilities of regulations, study protocols, supply chains, and patient recruitment — all the details that must be worked out before a study can even begin. The pressure is always there. The longer it takes for a study to start, the longer it takes to complete.

Read More

Spotlight

Genetics Society of America

The mission of the Genetics Society of America (GSA) is to deepen our understanding of the living world by advancing the field of genetics. It does this by: Fostering an international community of geneticists by promoting interaction among geneticists (including microbial, plant, animal, human, and population and theoretical geneticists) while cultivating a community of thought leaders in the field. Ensuring genetics fulfills its potential for broad impact by facilitating the application of genetic tools and approaches in biological research.

Events